Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human gamma MSH ELISA Kit (AC3633)
Cat.#: ASET-2222
Specifications
Description Human gamma MSH ELISA Kit allows for the in vitro quantitative determination of human gamma MSH concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1446 Human Semaphorin 7a ELISA Kit (AC2857) Quantitative inquiry ASET-1014 Human iNOS ELISA Kit (AC2425) Quantitative inquiry ASET-1029 Human APLP2 ELISA Kit (AC2440) Quantitative inquiry ASET-2358 Human Glutamate Receptor 1 (AMPA subtype) ELISA Kit (AC3769) Quantitative inquiry ASET-1262 Human PACAP ELISA Kit (AC2673) Quantitative inquiry ASET-1498 Mouse VEGFC ELISA Kit (AC2909) Quantitative inquiry ASET-1465 Human Meteorin ELISA Kit (AC2876) Quantitative inquiry ASET-1700 Mouse NG2 ELISA Kit (AC3111) Quantitative inquiry ASET-1297 Rat Myelin Basic Protein ELISA Kit (AC2708) Quantitative inquiry ASET-1481 Human Laminin alpha 1 ELISA Kit (AC2892) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket